EdgarLookup

LENSAR, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Winer Gary M Purchase 1,000 $4.25 $4,250 35,552 Nov 17, 2022
Winer Gary M Purchase 2,000 $6.00 $12,000 34,552 Aug 17, 2022
LINK WILLIAM J PHD Award / Grant 4,285 511,979 May 25, 2022
MCLAUGHLIN JOHN PETER Award / Grant 4,285 44,343 May 25, 2022
O'Farrell Elizabeth G. Award / Grant 4,285 11,285 May 25, 2022
Winer Gary M Award / Grant 4,285 29,552 May 25, 2022
WEISNER AIMEE S Award / Grant 4,285 4,285 May 25, 2022
LINDSTROM RICHARD L MD Award / Grant 4,285 207,748 May 25, 2022
STAAB THOMAS R II Chief Financial Officer Award / Grant 15,000 131,409 Jan 11, 2022
CURTIS NICHOLAS T Chief Executive Officer Award / Grant 30,000 770,850 Jan 11, 2022
Connaughton Alan B. Chief Operating Officer Award / Grant 15,000 266,221 Jan 11, 2022
Winer Gary M Award / Grant 4,026 25,267 Dec 7, 2020
LINK WILLIAM J PHD Award / Grant 80,157 507,694 Dec 7, 2020
Connaughton Alan B. Chief Operating Officer Award / Grant 39,195 251,221 Dec 7, 2020
STAAB THOMAS R II Chief Financial Officer Award / Grant 19,276 115,657 Dec 7, 2020
CURTIS NICHOLAS T Chief Executive Officer Award / Grant 116,622 731,585 Dec 7, 2020
LINDSTROM RICHARD L MD Award / Grant 32,127 203,463 Dec 7, 2020
Winer Gary M Award / Grant 51 21,241 Oct 6, 2020
PDL BIOPHARMA, INC. Purchase 8,703 $11.16 $97,125 8,667,397 Oct 1, 2020